Last updated on November 2019

A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+) Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib


Find a site near you

Start Over

Florida Hospital Medical Group

Orlando, FL United States
8.34miles
  Connect »